How should I evaluate and manage a patient with bronchitis, distinguishing acute from chronic forms?

Evaluation and Management of Bronchitis

For acute bronchitis in immunocompetent adults, do not routinely order investigations or prescribe antibiotics, antitussives, bronchodilators, or corticosteroids—focus on patient education about the 2-3 week natural course and symptomatic care only 1.

Distinguishing Acute from Chronic Bronchitis

Acute Bronchitis

• Clinical presentation: Acute cough (typically lasting 2-3 weeks) with or without sputum production, often following upper respiratory symptoms 1, 2
• Key exclusions: Must rule out pneumonia, asthma exacerbation, COPD exacerbation, pertussis, and heart failure 1
• Red flags requiring further workup: Tachypnea, tachycardia, dyspnea, abnormal lung findings, or cough persisting >2 weeks with paroxysmal features 3

Chronic Bronchitis

• Diagnostic criteria: Productive cough occurring most days for ≥3 months per year for ≥2 consecutive years, with other cardiac/pulmonary causes excluded 4
• Underlying pathology: Usually related to cigarette smoking or environmental irritant exposure, often progresses to COPD 4

Management of Acute Bronchitis

Initial Evaluation

No routine testing is recommended 1. Specifically avoid:

• Chest x-ray (unless pneumonia suspected)
• Spirometry or peak flow
• Sputum cultures
• Viral PCR
• Inflammatory markers (CRP, procalcitonin)

Treatment Approach

Antibiotics are NOT indicated 1. The 2020 CHEST guidelines are explicit that antibiotics provide minimal benefit (reducing cough by only 0.5 days) while exposing patients to adverse effects including allergic reactions, GI symptoms, and C. difficile infection 2, 3.

Also avoid prescribing:

• Antitussives
• Inhaled beta-agonists
• Inhaled anticholinergics
• Inhaled or oral corticosteroids
• Oral NSAIDs

When to Reconsider

Reassessment is warranted if symptoms persist or worsen 1. At that point, consider:

• Chest x-ray
• Sputum culture
• Peak flow measurements
• Complete blood count
• Inflammatory markers

Important caveat: In retrospective studies, 65% of patients with recurrent "acute bronchitis" episodes actually had mild asthma 1. Consider underlying asthma if pattern emerges.

Antibiotic Exceptions

Consider antibiotics only if 1:

• Bacterial superinfection develops (worsening with purulent sputum)
• Pertussis is suspected (to reduce transmission)
• Patient is immunocompromised
• Patient has chronic cardiac/respiratory disease

Management of Chronic Bronchitis

Stable Disease

Smoking cessation is paramount—90% of patients experience cough resolution after quitting 4. This is the single most effective intervention.

Bronchodilator therapy (Grade A recommendations) 4:

• Short-acting beta-agonists: Control bronchospasm, relieve dyspnea, may reduce cough
• Ipratropium bromide: Reduces cough frequency and severity, decreases sputum volume
• Theophylline: Improves cough but requires careful monitoring for side effects and drug interactions

Combined therapy 4:

• Long-acting beta-agonist + inhaled corticosteroid for patients with FEV₁ <50% or frequent exacerbations (Grade A)

Avoid in stable disease 4:

• Prophylactic antibiotics
• Expectorants (no proven benefit)
• Postural drainage/chest physiotherapy
• Oral corticosteroids

Acute Exacerbation of Chronic Bronchitis

Clinical definition: Sudden deterioration with increased cough, sputum volume, sputum purulence, and/or dyspnea, often preceded by upper respiratory symptoms 4. Must exclude pneumonia, heart failure, pulmonary embolism.

Treatment algorithm 4:

1. Bronchodilators (Grade A):

   • Start with short-acting beta-agonist OR anticholinergic
   • If inadequate response, add the other agent at maximal dose
   • Do NOT use theophylline during acute exacerbations (Grade D)

2. Antibiotics (Grade A) 4:

   • Indicated for moderate-to-severe exacerbations, especially with purulent sputum
   • Most beneficial in patients with all three cardinal symptoms (increased cough, sputum, dyspnea) and baseline severe airflow obstruction
   • Target S. pneumoniae, H. influenzae, M. catarrhalis

3. Systemic corticosteroids 4:

   • 2-week course recommended (equivalent efficacy to 8 weeks with fewer side effects)
   • Use oral or IV depending on severity

4. Avoid 4:

   • Expectorants
   • Mucokinetic agents
   • Postural drainage/chest physiotherapy

Common Pitfalls

• Over-prescribing antibiotics for acute bronchitis: The most recent high-quality guideline 1 is unequivocal—antibiotics are not routinely indicated
• Missing underlying asthma: Consider this diagnosis in patients with recurrent episodes
• Failing to emphasize natural history: Patients expect 2-3 weeks of cough; setting this expectation reduces antibiotic-seeking behavior 2, 3
• Using theophylline during acute exacerbations: This is explicitly contraindicated despite its benefit in stable disease 4

Effective Communication Strategies

To maintain patient satisfaction while avoiding unnecessary antibiotics 2, 3:

• Call it a "chest cold" rather than "bronchitis"
• Explain the 2-3 week expected duration
• Consider delayed antibiotic prescriptions (fill only if worsening after 5-7 days)
• Emphasize that antibiotics provide minimal benefit (half-day reduction) with real risks